The trains can travel from the "heart of midtown Manhattan to the Hamptons in one hour and 35 minutes," LIRR president Rob Free previously told Newsday. "That's the most affordable, fastest and ...

Out of thousands of entries, a St. Aidan’s eighth grader’s artwork has been selected to support the LIRR’s quest for safety – This time, in the form of a pair of socks. Marielle ...

The urgent need to repair a tunnel damaged by Superstorm Sandy is reigniting tensions between LIRR and Amtrak officials. At stake: the commutes of tens of thousands of train riders who pass nine ...

Regeneron has agreed to buy 23andMe, the once buzzy genetic testing company, out of bankruptcy for $256 million under a court-supervised sale process. 23andMe declared bankruptcy in March and ...

After being closed for eight months, the western half of the platform has officially reopened to the public, marking a key milestone in the massive infrastructure upgrade. Trump’s cabinet turns ...

The state Department of Transportation seems ready to run out the clock on a $10 deal to help electrify Long Island’s busiest LIRR line — which could cost Suffolk County over $2 million in ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s ...

A Long Island woman has been indicted for allegedly stabbing her ex-boyfriend to death outside an LIRR train station in Bay Shore earlier this month, prosecutors announced Monday. Nikeya Barker ...

agreed to be purchased out of bankruptcy on Monday for $256 million, a steep fall from the $6 billion peak it achieved in 2021. The company would live on inside biotech Regeneron, which said it ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

May 19 (UPI) --Regeneron Pharmaceuticals announced Monday it plans to purchase human genetics and biotechnology firm 23andMe from bankruptcy protection in a $256 million deal. Regeneron acquired ...

Regeneron Pharmaceuticals on Monday announced it is buying 23andMe out of bankruptcy for $256 million – taking with it the company’s extensive trove of genetic samples and data. It will ...